Method for rapidly filtering and screening medulla ossium substrate stem cell

A rapid filtration and stem cell technology, applied in the direction of bone/connective tissue cells, animal cells, sterilization methods, etc., can solve the problems of long time, high cost, and difficulty in clinical use, and achieve short time consumption, little interference, and benefit The effect of clinical use

Active Publication Date: 2009-07-01
SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1) Although the separation method of flow cytometry separates cells quickly and has high purity, it is expensive, and it is difficult to separate trace cells with too low content, and it cannot handle a large number of cell samples, and it is also difficult to obtain a sterile cell suspension
2) The immunomagnetic bead separation method has a great impact on the activity of cells, and the recovery rate is only 60%-75%, which may lead to complete inactivation of cells. The same operation is more complicated and expensive
However, it takes a long time, involves in vitro culture of cells, and is difficult for clinical use.
4) Density gradient centrifugation is a commonly used method for concentrating and separating cells, but it often requires the use of a separation medium (such as Ficoll or Hypaque solution, etc.). Washing away the separation medium, maintaining the sterility of the entire operation requires special equipment, which is expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for rapidly filtering and screening medulla ossium substrate stem cell
  • Method for rapidly filtering and screening medulla ossium substrate stem cell
  • Method for rapidly filtering and screening medulla ossium substrate stem cell

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] see Image 6 .

[0023] Image 6 There are first one-way flap valve 1, switch valve 2, second one-way flap valve 3, exhaust hole 4, peristaltic pump 5, filter box 6, injection pump 8, first right connecting pipe 11, first Left connecting pipe 12, second right connecting pipe 13, second left connecting pipe 14, first pipeline 31, second pipeline 32, filter screen 61, movable cover 62.

[0024] The working method of the present invention is as follows: open the switch valve 2, the 250ml bone marrow blood after the anticoagulant treatment enters the first pipeline 31 through the injection pump 8, close the switch valve 2, open the switch of the peristaltic pump 5, and the bone marrow blood flows into the second right connecting pipe respectively 13. Enter the filter box 6 for filtration, and then flow to the second pipeline 32. Under the peristalsis of the peristaltic pump 5 and the filter screen 61, the bone marrow stromal stem cells in 250ml of bone marrow blood are se...

Embodiment 2

[0028] see Figure 7 .

[0029] Figure 7 There are first one-way flap valve 1, switch valve 2, second one-way flap valve 3, exhaust hole 4, peristaltic pump 5, filter box 6, injection pump 8, first right connecting pipe 11, first Left connecting pipe 12, second right connecting pipe 13, second left connecting pipe 14, first pipeline 31, second pipeline 32, filter screen 61, movable cover 62.

[0030] The working method of the present invention is as follows: open the switch valve 2, the 300ml bone marrow blood after anticoagulant treatment enters the first pipeline 31 through the injection pump 8, close the switch valve 2, open the switch of the peristaltic pump 5, and the bone marrow blood flows into the second right connecting pipe respectively 13. Enter the filter box 6 for filtration, and then flow to the second pipeline 32. Under the peristalsis of the peristaltic pump 5 and the filter screen 61, the bone marrow stromal stem cells in 300ml of bone marrow blood are sele...

Embodiment 3

[0034] see Figure 8 , 9, 10.

[0035] Figure 8 There are filter complex 60, filter screen 61, bone marrow stromal cells 71, other bone marrow cells 72,

[0036] Figure 9 There are filter complex 60, filter screen 61, bone marrow stromal cells 71, other bone marrow cells 72,

[0037] Figure 10 There are filter complex 60, filter screen 61, bone marrow stromal stem cells 71, other bone marrow cells 72, and stem cell-scaffold composite material 7.

[0038] During the operation, 250ml of bone marrow blood was drawn for anticoagulant treatment. Tricalcium phosphate is selected as the material of the filter screen 61, and the pore size of the filter holes can allow bone marrow cells to pass through smoothly. The anticoagulated bone marrow blood is injected into the filter complex 60 for filtering ( Figure 8 ). Using the unique adhesion characteristics of bone marrow stromal stem cells, the bone marrow stromal stem cells 71 are selectively retained and enriched on the fi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a filtering method, in particular to a method for quickly filtering and screening bone marrow stromal cells. The method adopts the technical proposal that the method for quickly filtering and screening the bone marrow stromal cells comprises the following steps: firstly, performing anticoagulant treatment on bone marrow blood to be used; secondly, filtering the bone marrow blood after anticoagulant treatment through a filtration recombiner; and thirdly, collecting stem cell-frame composite materials. The method has the advantages that the method quickly recombines the cells and a vector (namely a filter screen material) when filtering and screening the bone marrow stromal cells simultaneously, so as to integrate the two procedures of cell screening and cell-vector combination into a whole. The filtering method has short time consumption, does not need in vitro culture, can be simultaneously performed in an operation, and is more favorable for clinic use because the volume of the screened stromal cells is smaller than that of cell suspension finally obtained by density gradient centrifugation technology.

Description

technical field [0001] The invention relates to a filtering method, in particular to a method for rapidly filtering and screening bone marrow stromal stem cells. Background technique [0002] The repair of bone defects often requires bone grafting or bone substitute materials to fill, and the current research hotspot in tissue engineering in this field is the scaffold carrier compounded with stem cells. Bone marrow stromal stem cells can be isolated by adherent culture or density gradient centrifugation, and then expanded in vitro. Although bone marrow stromal stem cells can be isolated in vitro and scaffolds containing cells can be prepared, they are still in the laboratory research stage and need to be implanted. For the human body, there are still many technical and ethical problems, and the cultivation cycle is long, easy to be polluted, and the cost is high, which affects the clinical application and promotion. [0003] At present, the cell screening techniques mainly ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/08C12M1/12C12N5/0775
Inventor 干耀恺戴尅戎汤亭亭
Owner SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products